Survivin, the smallest member of the Inhibitor of Apoptosis (IAP) protein family [5,6], is selectively overexpressed in almost every human tumour [7,8,9,10] and consistently identified as a risk factor for poor prognosis and disease recurrence. The gene discussed is BIRC5; the disease is neoplasm.